South Korean Parliament Passes Law Banning Type Of Cloning, Broadening Embryonic Stem Cell Research
By Agence France-Presse,
Agence France-Presse
| 05. 20. 2008
South Korea's Parliament on Friday passed a law that bans inserting human somatic cells -- or cells that can form tissues and organs -- into animal eggs and allows researchers to use human embryonic stem cells to treat "general" diseases, Agence France-Presse reports. A previous law only allowed embryonic stem cells to be used for research to treat infertility and "rare or incurable" diseases, according to Agence France-Presse.
The ban on cross-species cloning is punishable by up to three years in jail, according to the country's Health Ministry. Kim Seung-Il, a health ministry official, said, "This law is aimed at enhancing bioethics." Park Se-Pill, a cloning expert, said the law "will serve as a very serious hindrance to research into cloning," adding that he and colleagues often used animal eggs in their research "because many eggs were needed while human eggs were difficult to obtain." Park said that South Korea is "going backward while other countries move ahead" with the research (Agence France-Presse, 5/16).
Related Articles
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors
| 03.25.2026
A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...
By Charles Pulliam-Moore, The Verge | 03.21.2026
Like many people, director Valerie Veatch was intrigued when OpenAI first released its Sora text-to-video generative AI model to the public in 2024. Though she didn’t fully understand the technology, she was curious about what it could do, and she...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...